Overview
Marie Follo practices in Freiburg, Germany. Ms. Follo is rated as an Experienced expert by MediFind in the treatment of Myeloproliferative Neoplasms (MPN). Her top areas of expertise are Anaplastic Large Cell Lymphoma, T-Cell Lymphoma, Graft Versus Host Disease (GvHD), and Multiple Myeloma.
Her clinical research consists of co-authoring 142 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 3 articles in the study of Myeloproliferative Neoplasms (MPN).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Anaplastic Large Cell LymphomaMs. Follo isAdvanced. Learn about Anaplastic Large Cell Lymphoma.
- Graft Versus Host Disease (GvHD)
- Multiple MyelomaMs. Follo isAdvanced. Learn about Multiple Myeloma.
- T-Cell LymphomaMs. Follo isAdvanced. Learn about T-Cell Lymphoma.
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Follo isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaMs. Follo isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Aplastic AnemiaMs. Follo isExperienced. Learn about Aplastic Anemia.
- AstrocytomaMs. Follo isExperienced. Learn about Astrocytoma.
- Autosomal Dominant Hyper IgE SyndromeMs. Follo isExperienced. Learn about Autosomal Dominant Hyper IgE Syndrome.
- Brain TumorMs. Follo isExperienced. Learn about Brain Tumor.